Share Prices & Company Research

Market News

15 Dec 2020 | 10:20

JPM upgrades Redrow, downgrades Berkeley

(Sharecast News) - JPMorgan Cazenove upgraded Redrow and downgraded Berkeley on Tuesday as it took a look at the UK housebuilding sector and became more positive on the outlook. The bank noted the sector has been a Covid-19 loser this year, underperforming the market by eight percentage points due to lockdown-linked stoppages and continued uncertainty on Brexit, partly offset by government support in the form of a furlough scheme and stamp duty holiday.

"We take an increasingly positive stance on the sector's outlook as the concerns into next year are well flagged and shift the skew of our preference from quality to value as we see an improved risk-reward," it said.

JPM said it continues to view the structural backdrop as positive, supported by an undersupplied market and affordability levels consistent with the long-term average.

"While the quality names outperformed on a year-to-date basis, the value trade since October had its effect within the sector as well," it said. "Heading into 2021, we are now shifting the skew of our recommendations toward value after strong outperformance of the quality names in 2020."

JPM upgraded Redrow to 'overweight' from 'neutral' and lifted the price target to 600p from 520p, saying it sees the stock as the near-term pick for the 'value trade'.

The bank downgraded Berkeley to 'neutral' from 'overweight' and cut the price target to 4,900p from 5,200p. It stuck with 'overweight' rated Persimmon as its 'medium-term pick' and maintained its 'underweight' stance on Crest Nicholson.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 7th December 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.